Automated Versus Standard Physiotherapy for Upper Limb Rehabilitation in Patients With Acquired Brain Lesions

Sponsor
Krankenhaus Bozen (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01398553
Collaborator
Valduce Hospital (Other)
0
2
2
57
0
0

Study Details

Study Description

Brief Summary

The Armeo Spring has proven its effectiveness in the rehabilitation of acute stroke patients. It neutralizes limb weight, enabling patients to use residual control in both arm and hand and to follow exercises guided by simulations of real-life challenges. The Armeo Spring incorporates wrist pronation and supination, allowing patients to enhance functional reaching patterns.

Aim of the study is to compare the Armeo device with standard physiotherapy in chronic patients with acquired brain lesions.

The result of the trial should show which treatment is more effective in the clinical practice. A significant better outcome of one arm should suggest to follow one treatment strategy more than the other.

Condition or Disease Intervention/Treatment Phase
  • Device: Armeo Spring
  • Other: conventional physiotherapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Armeo® Versus Standard Physiotherapy for Upper Limb Rehabilitation in Patients With Acquired Brain Lesions
Study Start Date :
Mar 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Armeo Spring

Device: Armeo Spring
30min Armeo Spring + 15min task oriented therapy over 6 weeks Frequency: 3 x/week
Other Names:
  • group A
  • Active Comparator: conventional physiotherapy

    Other: conventional physiotherapy
    30min occupational therapy(15min ADL-training, 15min repetitive training) + 15min task oriented therapy over 6 weeks Frequency: 3x/week
    Other Names:
  • group B
  • Outcome Measures

    Primary Outcome Measures

    1. Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke [Enrollment]

    2. Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke [Baseline]

    3. Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke [6 weeks]

    4. Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke [8 weeks]

    5. Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke [12 weeks]

    Secondary Outcome Measures

    1. Upper Extremity Motor Activity Log for measuring real use of the upper limb [Enrolment]

    2. Upper Extremity Motor Activity Log for measuring real use of the upper limb [Baseline]

    3. Upper Extremity Motor Activity Log for measuring real use of the upper limb [6 weeks]

    4. Upper Extremity Motor Activity Log for measuring real use of the upper limb [8 weeks]

    5. Upper Extremity Motor Activity Log for measuring real use of the upper limb [12 weeks]

    6. Wolf Motor Function Test for measurement of timed joint-segment movements [Enrolment]

    7. Wolf Motor Function Test for measurement of timed joint-segment movements [Baseline]

    8. Wolf Motor Function Test for measurement of timed joint-segment movements [6 weeks]

    9. Wolf Motor Function Test for measurement of timed joint-segment movements [8 weeks]

    10. Wolf Motor Function Test for measurement of timed joint-segment movements [12 weeks]

    11. Clinical Global Impression Score for the measurement of change over time of the illness' severity [Enrolment]

    12. Clinical Global Impression Score for the measurement of change over time of the illness' severity [Baseline]

    13. Clinical Global Impression Score for the measurement of change over time of the illness' severity [6 weeks]

    14. Clinical Global Impression Score for the measurement of change over time of the illness' severity [8 weeks]

    15. Clinical Global Impression Score for the measurement of change over time of the illness' severity [12 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 6 month after the onset of disease

    • acquired brain lesions in adults with upper limb hemiparesis

    • modified Ashworth <= 3

    • muscular strength MRC =>1 mano; MRC =>2 elbow e shoulder

    • Fugl Meyer => 18

    Exclusion Criteria:
    • NYHA >III

    • MMSE (mini mental status examination test) < 24

    • muscular strength (MRC) < 1

    • Dystonia, spasticity (Ashworth => 3)

    • articular contractions in the upper limb

    • previous upper limb lesions

    • cognitive/language impairment likely to influence assessments

    • any diagnosis likely to interfere with rehabilitation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Valduce Hospital Costa Masnaga Lombardia Italy 23845
    2 Krankenhaus Bozen Bozen Südtirol Italy 39100

    Sponsors and Collaborators

    • Krankenhaus Bozen
    • Valduce Hospital

    Investigators

    • Principal Investigator: Peter Zelger, MD, Krankenhaus Bozen
    • Study Director: Franco Molteni, MD, Valduce Hospital
    • Study Chair: Elisabeth Hofer, MD, Krankenhaus Bozen
    • Study Chair: Mauro Rossini, MSc, Valduce Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Krankenhaus Bozen
    ClinicalTrials.gov Identifier:
    NCT01398553
    Other Study ID Numbers:
    • Gesundheitsbezirk Bozen
    First Posted:
    Jul 20, 2011
    Last Update Posted:
    Sep 7, 2016
    Last Verified:
    Sep 1, 2016
    Keywords provided by Krankenhaus Bozen
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 7, 2016